NanoSessions: Resolution, Evolution, and What’s Next for LEDs

 

Much of the focus on LED technology has been about resolution, but there comes a point where screens may have a sharper resolution than what the eye can see. In this episode of NanoSessions, Dan Rossborough, Director of Strategic Projects with NanoLumens, explains that the Pro AV industry has reached this peak, but at the end of the day it’s all about perception.

“Resolution is directly tied to pixel pitch or the density of pixels in an area. Resolution is also in the context of viewing distance. So, yes, we’ve come to a point where resolution is probably at its max, but what we’re most concerned with is helping architects and designers find the appropriate products based on viewing range and resolution,” Rossborough said.

While in most scenarios, LED screens are flat, NanoLumens began to look at screens from a different perspective. “LEDs have been traditionally flat. But if you look at the roots of NanoLumens, the company’s foundation has always been around R&D. We have many more engineers than sales professionals. We really wanted to revolutionize the industry,” Rossborough said.

“LEDs were initially used outdoors. We didn’t just want to take the outdoor solution and bring it indoors. That’s when we started looking at the screen as a material, one that could be flexible,” he said.

NanoLumens screens can now fit any surface, and they are moving toward compound curvatures that are nonlinear. It all started with the company’s first direct view LED display in 2012. “Coca-Cola came to us in 2012 and had a hallway that they wanted screens all down the hallway. They originally spec’d 60 plasma screens. The catch was that these screens had to be front serviceable. So, we started developing a product and created the first fully front serviceable direct view LED. We installed them, and they are still running today,” Rossborough said.

This first foray into customization has become the specialty of NanoLumens. “Most of the products we have now started from a customer needing something that didn’t exist. Everything we build is application specific and bespoke. Why? There are not two architectures that are identical, so why should displays be the same,” Rossborough said.

For the latest news, videos, and podcasts in the Pro AV Industry, be sure to subscribe to our industry publication. A new episode of the Pro AV Show drops every Thursday.

Follow us on social media for the latest updates in B2B!

Twitter – @ProAVMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More